BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2007
View Archived Issues
Medivir completes enrollment of phase III program for topical Lipsovir
Read More
bioMerieux to develop companion test for Ipsen's BN-83495
Read More
Phosphagenics submits IND for transdermal oxycodone for chronic pain
Read More
Initial phase I results show IMO-2055 plus chemotherapy feasible for solid tumors
Read More
XL-647 demonstrates antitumor activity in non-small cell lung cancer patients
Read More
Recent data on triple angiokinase inhibitor BIBF-1120 in NSCLC presented
Read More
Retreatment with Tookad phototherapy feasible and active in prostate cancer
Read More
Preclinical data on potential targets for the development of agents for sleep disorders
Read More
Cannasat Therapeutics' pain therapy delivered with IntelGenx technology in phase I trial
Read More
Asubio Pharma acquires exclusive rights to Kuvan NDA data for filing in Japan
Read More
Pharmacopeia begins phase IIa study of PS-433540 for hypertension
Read More
Patient enrollment completed for Sciele Pharma's pivotal phase III trial of glycopyrrolate
Read More
Microbia and Forest to codevelop and comarket linaclotide for gastrointestinal disorders
Read More
Vasogen to begin 300-patient confirmatory study of Celacade technology
Read More
FDA allows IND exemption for Genta's tablet formulation of G-4544
Read More
Positive tesofensine results from NeuroSearch TIPO-1 study in obesity
Read More
Polydex reports final results from phase II trial of Ushercell for BV
Read More
Schering-Plough begins two phase III studies of CCR5 antagonist vicriviroc
Read More
Xenomics and Ipsogen sign licensing agreement for diagnostic assay for AML
Read More
Idera begins dosing patients in phase I trial of IMO-2125 for HCV
Read More
Novel agents for cancer treatment covered in recent patent literature
Read More
Novel therapeutic agents for asthma disclosed in recent patents
Read More
Vion begins phase I/II brain tumor trial combining Cloretazine and Temodar
Read More
Hollis-Eden files IND for HE-3286 for inflammation
Read More
Recent patents report new therapeutic agents for disorders associated with impaired metabolism
Read More
Pegnaloxol -- a potential treatment for opioid-induced bowel dysfunction
Read More
SA-1-204 effective against extended spectrum beta-lactamases
Read More
Snapshots of clinical results in sleep research
Read More